Noile-Immune Biotech Inc. (TYO:4893)
Japan · Delayed Price · Currency is JPY 116.00
-2.00 (-1.69%)
Jun 24, 2026, 3:30 PM JST
Noile-Immune Biotech Market Cap
Noile-Immune Biotech has a market cap or net worth of 5.03 billion as of June 24, 2026. Its market cap has decreased by -28.67% in one year.
Market Cap
5.03B
Enterprise Value
1.29B
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
116.00
Market Cap Chart
Since June 28, 2023, Noile-Immune Biotech's market cap has decreased from 30.89B to 5.03B, a decrease of -83.70%. That is a compound annual growth rate of -45.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 5.03B | -12.59% |
| Dec 30, 2025 | 5.76B | -21.76% |
| Dec 30, 2024 | 7.36B | -19.77% |
| Dec 29, 2023 | 9.17B | -70.30% |
| Jun 28, 2023 | 30.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 6.72B |
| Kidswell Bio | 6.60B |
| Carna Biosciences | 6.59B |
| Soiken Holdings | 6.33B |
| BrightPath Biotherapeutics | 6.11B |
| CellSource | 5.87B |
| Chiome Bioscience | 5.05B |
| Kohjin Bio | 4.92B |